Eli Lilly (LLY) said Thursday it has expanded its LillyDirect digital platform to add tools that link to in-person and telehealth providers for people in the US with Alzheimer's disease.
In contrast with other conditions on the platform, the resources for Alzheimer's disease won't include mail order pharmacy options to Lilly drugs but will focus on education and ways to connect people with independent provider options, according to the company.
The new options include independent doctor locator tool Healthgrades and a link to Synapticure, Eli Lilly said.
Price: 822.71, Change: -4.05, Percent Change: -0.49
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。